Tumor cell-specific loss of p53 protein in a unique in vitro model of human breast tumor progression

Xiao Long Liu, Hamid Band, Qingshen Gao, David E. Wazer, Quiming Chu, Vimla Band

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Mutations of the p53 gene are the most frequent genetic lesion in breast cancer. Here, we examined p53 expression in a unique in vitro model of tumor progression derived from a single breast cancer patient (21T series). While the normal mammary epithelial, fibroblast and mesothelial cells derived from this patient expressed easily detectable functional p53 protein, the primary as well as metastatic tumor cell lines demonstrated a lack of p53 protein synthesis. 21T tumor cells failed to exhibit G1 cell cycle arrest upon exposure to γ-irradiation, and their growth was suppressed by transfection of a normal p53 cDNA, demonstrating a lack of p53-mediated function in these cells. No p53 gene deletion or rearrangements were detectable. PCR and sequence analysis of the entire coding region of p53 gene revealed a novel mutation, an insertion of a single T within codon 33, which resulted in a frame-shift and early termination. The same mutation was observed in all 21T tumor cell lines. These results demonstrate a tumor cell-specific loss of p53 protein due to a frame-shift mutation, and suggest that p53 loss may occur at a relatively early step in breast tumorigenesis before metastatic seeding or emergence of tumor heterogeneity. In addition, the availability of normal and tumor-derived epithelial cells with known p53 sequences from a single breast cancer patient should facilitate understanding of the p53 regulation in mammary cells.

Original languageEnglish (US)
Pages (from-to)1969-1973
Number of pages5
JournalCarcinogenesis
Volume15
Issue number9
DOIs
StatePublished - Sep 1 1994

Fingerprint

Progression
Tumors
Tumor
Cells
Breast Neoplasms
Proteins
Protein
p53 Genes
Cell
Breast
Neoplasms
Mutation
Tumor Cell Line
Breast Cancer
Genes
G1 Phase Cell Cycle Checkpoints
Gene
Frameshift Mutation
Model
Gene Rearrangement

ASJC Scopus subject areas

  • Cancer Research

Cite this

Tumor cell-specific loss of p53 protein in a unique in vitro model of human breast tumor progression. / Liu, Xiao Long; Band, Hamid; Gao, Qingshen; Wazer, David E.; Chu, Quiming; Band, Vimla.

In: Carcinogenesis, Vol. 15, No. 9, 01.09.1994, p. 1969-1973.

Research output: Contribution to journalArticle

Liu, Xiao Long ; Band, Hamid ; Gao, Qingshen ; Wazer, David E. ; Chu, Quiming ; Band, Vimla. / Tumor cell-specific loss of p53 protein in a unique in vitro model of human breast tumor progression. In: Carcinogenesis. 1994 ; Vol. 15, No. 9. pp. 1969-1973.
@article{b6443a27df354005aef0f1862a03bc5e,
title = "Tumor cell-specific loss of p53 protein in a unique in vitro model of human breast tumor progression",
abstract = "Mutations of the p53 gene are the most frequent genetic lesion in breast cancer. Here, we examined p53 expression in a unique in vitro model of tumor progression derived from a single breast cancer patient (21T series). While the normal mammary epithelial, fibroblast and mesothelial cells derived from this patient expressed easily detectable functional p53 protein, the primary as well as metastatic tumor cell lines demonstrated a lack of p53 protein synthesis. 21T tumor cells failed to exhibit G1 cell cycle arrest upon exposure to γ-irradiation, and their growth was suppressed by transfection of a normal p53 cDNA, demonstrating a lack of p53-mediated function in these cells. No p53 gene deletion or rearrangements were detectable. PCR and sequence analysis of the entire coding region of p53 gene revealed a novel mutation, an insertion of a single T within codon 33, which resulted in a frame-shift and early termination. The same mutation was observed in all 21T tumor cell lines. These results demonstrate a tumor cell-specific loss of p53 protein due to a frame-shift mutation, and suggest that p53 loss may occur at a relatively early step in breast tumorigenesis before metastatic seeding or emergence of tumor heterogeneity. In addition, the availability of normal and tumor-derived epithelial cells with known p53 sequences from a single breast cancer patient should facilitate understanding of the p53 regulation in mammary cells.",
author = "Liu, {Xiao Long} and Hamid Band and Qingshen Gao and Wazer, {David E.} and Quiming Chu and Vimla Band",
year = "1994",
month = "9",
day = "1",
doi = "10.1093/carcin/15.9.1969",
language = "English (US)",
volume = "15",
pages = "1969--1973",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Tumor cell-specific loss of p53 protein in a unique in vitro model of human breast tumor progression

AU - Liu, Xiao Long

AU - Band, Hamid

AU - Gao, Qingshen

AU - Wazer, David E.

AU - Chu, Quiming

AU - Band, Vimla

PY - 1994/9/1

Y1 - 1994/9/1

N2 - Mutations of the p53 gene are the most frequent genetic lesion in breast cancer. Here, we examined p53 expression in a unique in vitro model of tumor progression derived from a single breast cancer patient (21T series). While the normal mammary epithelial, fibroblast and mesothelial cells derived from this patient expressed easily detectable functional p53 protein, the primary as well as metastatic tumor cell lines demonstrated a lack of p53 protein synthesis. 21T tumor cells failed to exhibit G1 cell cycle arrest upon exposure to γ-irradiation, and their growth was suppressed by transfection of a normal p53 cDNA, demonstrating a lack of p53-mediated function in these cells. No p53 gene deletion or rearrangements were detectable. PCR and sequence analysis of the entire coding region of p53 gene revealed a novel mutation, an insertion of a single T within codon 33, which resulted in a frame-shift and early termination. The same mutation was observed in all 21T tumor cell lines. These results demonstrate a tumor cell-specific loss of p53 protein due to a frame-shift mutation, and suggest that p53 loss may occur at a relatively early step in breast tumorigenesis before metastatic seeding or emergence of tumor heterogeneity. In addition, the availability of normal and tumor-derived epithelial cells with known p53 sequences from a single breast cancer patient should facilitate understanding of the p53 regulation in mammary cells.

AB - Mutations of the p53 gene are the most frequent genetic lesion in breast cancer. Here, we examined p53 expression in a unique in vitro model of tumor progression derived from a single breast cancer patient (21T series). While the normal mammary epithelial, fibroblast and mesothelial cells derived from this patient expressed easily detectable functional p53 protein, the primary as well as metastatic tumor cell lines demonstrated a lack of p53 protein synthesis. 21T tumor cells failed to exhibit G1 cell cycle arrest upon exposure to γ-irradiation, and their growth was suppressed by transfection of a normal p53 cDNA, demonstrating a lack of p53-mediated function in these cells. No p53 gene deletion or rearrangements were detectable. PCR and sequence analysis of the entire coding region of p53 gene revealed a novel mutation, an insertion of a single T within codon 33, which resulted in a frame-shift and early termination. The same mutation was observed in all 21T tumor cell lines. These results demonstrate a tumor cell-specific loss of p53 protein due to a frame-shift mutation, and suggest that p53 loss may occur at a relatively early step in breast tumorigenesis before metastatic seeding or emergence of tumor heterogeneity. In addition, the availability of normal and tumor-derived epithelial cells with known p53 sequences from a single breast cancer patient should facilitate understanding of the p53 regulation in mammary cells.

UR - http://www.scopus.com/inward/record.url?scp=0027963525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027963525&partnerID=8YFLogxK

U2 - 10.1093/carcin/15.9.1969

DO - 10.1093/carcin/15.9.1969

M3 - Article

C2 - 7923592

AN - SCOPUS:0027963525

VL - 15

SP - 1969

EP - 1973

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 9

ER -